Physician

Ryan Michael Smith, DO, FACC

According to 2025 Medicare claims, Ryan Smith, DO, FACC (NPI: 1639157365) practices cardiology in the Urban Honolulu, HI market, with the plurality of this provider's patient population coming from Honolulu, HI. This provider's primary affiliated billing organization is REVIVE INFUSION CENTER LLC (NPI: 1558117622; TIN: 990893578) and primary practice location at 96817-1605.

Smith's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,174 traditional Medicare patients, billed 9,686 HCPCS/CPT codes, and received $510,811 in Medicare payments. The top billing code was 93880 (Ultrasound of both sides of head and neck blood flow). Part D data shows 3,788 prescription claims across 602 beneficiaries totaling $2,214,053 in drug costs, led by Vyndamax (Tafamidis). Open Payments data shows 38 records totaling $5,351. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $208,396 to $510,811. Similarly, Part D prescription costs have moved sharply higher in recent years, from $30,988 to $2,214,053. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$260K$521K2020 Medicare payment: $208,396 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $307,959 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $493,427 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $520,653 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $510,811 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
20202421,808$208,396
20215232,989$307,959
20229334,895$493,427
20231,09011,898$520,653
20241,1749,686$510,811

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$1.1M$2.2M2020 Drug cost: $30,988 (USD; Tot_Drug_Cst)2021 Drug cost: $234,780 (USD; Tot_Drug_Cst)2022 Drug cost: $605,902 (USD; Tot_Drug_Cst)2023 Drug cost: $1,509,206 (USD; Tot_Drug_Cst)2024 Drug cost: $2,214,053 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/RN/RN/R
2016N/RN/RN/R
2017N/RN/RN/R
2018N/RN/RN/R
2019N/RN/RN/R
202055122$30,988
2021171777$234,780
20223701,437$605,902
20235463,114$1,509,206
20246023,788$2,214,053

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
93880Ultrasound of both sides of head and neck blood flow246251$131
93306Ultrasound of heart with color-depicted blood flow, rate, direction and valve function473503$118
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more6551,571$87
93356Heart muscle strain imaging245262$29
93000Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report476820$10

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
VyndamaxTafamidis301,020$785,864
EliquisApixaban38026,939$509,176
EntrestoSacubitril/Valsartan17211,626$249,334
Repatha SureclickEvolocumab1599,436$182,977
JardianceEmpagliflozin1057,100$137,665

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.38$5,351Amgen Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Ryan Michael Smith, DO, FACC?

Tedicare shows public-source Medicare data for Ryan Michael Smith, DO, FACC (NPI 1639157365), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ryan Michael Smith, DO, FACC have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ryan Michael Smith, DO, FACC?

Ryan Michael Smith, DO, FACC is linked to REVIVE INFUSION CENTER LLC (billing NPI 1558117622) in the available physician profile data.

Does Ryan Michael Smith, DO, FACC have Open Payments data?

Ryan Michael Smith, DO, FACC has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.